Newsletter

Hospital-acquired bacterial pneumonia/ Ventilator-associated bacterial pneumonia
Pathogens, treatment guidelines, off-label therapies, and highly competitive HABP/VABP markets
Hospital-acquired bacterial pneumonia/ Ventilator-associated bacterial pneumonia

More Whitepapers / Newsletters

Raynauds phenomenon Newsletter
Raynaud's phenomenon

Raynaud’s phenomenon (RP) is a condition that results in discoloration of fingers or toes caused by episodic vasospasm...

Chronic inflammatory demyelinating polyneuropathy market Newsletter
Chronic inflammatory demyelinating polyneuropathy market

A rare neurological disorder characterized by progressive weakness and impaired sensory function in the legs and arms...

Pompe disease Newsletter
Pompe disease

An autosomal metabolic disorder – Pompe disease results in deterioration of organs and tissues as a consequence of excess accumulation of glycogen..

Digital Therapeutics in Mental Health Whitepaper
Digital Therapeutics in Mental Health Whitepaper

Digital therapies are evidence-based clinical approaches powered by software applications designed to prevent, control or treat a particular disease or condition. While advances in technology-assisted therapies evolve...

Familial chylomicronemia syndrome Newsletter
Familial chylomicronemia syndrome

A rare autosomal recessive disorder, Familial chylomicronemia syndrome (FCS), affects 1 in 1 to 2 million people that prevents the body from breaking...